These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19055091)

  • 21. The impact of benzodiazepine use on methadone maintenance treatment outcomes.
    Brands B; Blake J; Marsh DC; Sproule B; Jeyapalan R; Li S
    J Addict Dis; 2008; 27(3):37-48. PubMed ID: 18956528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to "transferring methadone-stabilized pregnant patients to buprenorphine".
    Newman RG
    Am J Addict; 2006; 15(5):400; author reply 401-2. PubMed ID: 16966198
    [No Abstract]   [Full Text] [Related]  

  • 23. Dependent opioid users assessed for methadone treatment in Otago: patterns of drug use.
    Dore GM; Hargreaves G; Niven BE
    N Z Med J; 1997 May; 110(1043):162-5. PubMed ID: 9196499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methadone and the QT interval: relations to the serum concentrations of methadone and its enantiomers (R)-methadone and (S)-methadone.
    Skjervold B; Bathen J; Spigset O
    J Clin Psychopharmacol; 2006 Dec; 26(6):687-9. PubMed ID: 17110841
    [No Abstract]   [Full Text] [Related]  

  • 25. Methadone maintenance and male sexual dysfunction.
    Brown R; Balousek S; Mundt M; Fleming M
    J Addict Dis; 2005; 24(2):91-106. PubMed ID: 15784526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interactions with methadone and buprenorphine].
    Bakke E; Bachs L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(22):2364-6. PubMed ID: 19935937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental caries and sugar-containing liquid medicines for children in New Zealand.
    Durward C; Thou T
    N Z Dent J; 1997 Dec; 93(414):124-9. PubMed ID: 9470445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence based policy for illicit [corrected] drugs.
    Wood E
    BMJ; 2010 Jul; 341():c3374. PubMed ID: 20595256
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
    Popov P; Becka J; Wilczek H
    Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone Maintenance Therapy and the Dental Patient.
    Raymond G; Maloney W
    N Y State Dent J; 2015; 81(5):48-51. PubMed ID: 26521328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and implications of multi-drug abuse in a population of methadone-maintained women.
    Leifer ED; Goldman J; Finnegan LP
    NIDA Res Monogr; 1983 Apr; 43():322-8. PubMed ID: 6410267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A survey of factors influencing the prescribing of sugar-free medicines for children by a group of general medical practitioners in Northern Ireland.
    Bradley M; Kinirons M
    Int J Paediatr Dent; 1996 Dec; 6(4):261-4. PubMed ID: 9161194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methadone tolerance testing in drug misusers.
    Bakker A; Fazey C
    BMJ; 2006 Nov; 333(7577):1056-9. PubMed ID: 17110724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?
    Keen J; Oliver P; Rowse G; Mathers N
    Br J Gen Pract; 2003 Jun; 53(491):461-7. PubMed ID: 12939891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone.
    Shearer J; Mammen K; Bell J
    Drug Alcohol Rev; 2010 Mar; 29(2):138-43. PubMed ID: 20447220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New formulation of methadone for opioid dependence in France: acceptability and diversion/misuse liability.
    Eiden C; Léglise Y; Bertomeu L; Clavel V; Faillie JL; Petit P; Peyrière H
    Therapie; 2013; 68(2):107-11. PubMed ID: 23773351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study.
    Gossop M; Marsden J; Stewart D; Lehmann P; Strang J
    Br J Gen Pract; 1999 Jan; 49(438):31-4. PubMed ID: 10622013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone tolerance testing in drug misusers: beyond the edge of safety.
    Zador DA; Farrell M
    BMJ; 2006 Dec; 333(7579):1172-3; author reply 1173. PubMed ID: 17139004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.